STOPS
Dead / Abandoned — Abandoned — no statement of use filed (as of 19 Sept 2022)
What this means for you
This application is over — abandoned 19 Sept 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88565047
- Mark type
- Stylized text
- Filed
- 02 Aug 2019
- Published for opposition
- 23 Jun 2020
- Abandoned
- 19 Sept 2022
- Attorney of record
- Charlene A. Azema
Goods and services
- Class 001 — Chemicals: Oligonucleotide and polymer ingredients for use in the manufacture of pharmaceutical preparations in the nature of antiviral drugs
- Class 005 — Pharmaceuticals: Oligonucleotides for medical therapeutic purposes; nucleic acids for medical therapeutic purposes; pharmaceutical preparations, namely, antivirals; pharmaceutical preparations, namely, oligonucleotides and polymers that control viral replication; oligonucleotide and polymer preparations for therapeutic pharmaceutical purposes in the treatment of viral diseases; nucleic acid polymers for therapeutic medical use
Owner
- Aligos Therapeutics, Inc., South San Francisco, CA, US
- Aligos Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 19 Sept 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 19 Sept 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Nov 2021 — SOU EXTENSION 3 GRANTED
- 16 Nov 2021 — SOU EXTENSION 3 FILED
- 16 Nov 2021 — SOU TEAS EXTENSION RECEIVED
- 20 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Aug 2021 — SOU EXTENSION 2 GRANTED
- 18 Aug 2021 — SOU EXTENSION 2 FILED
- 18 Aug 2021 — SOU TEAS EXTENSION RECEIVED
- 07 Jan 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Jan 2021 — SOU EXTENSION 1 GRANTED
- 05 Jan 2021 — SOU EXTENSION 1 FILED
- 05 Jan 2021 — SOU TEAS EXTENSION RECEIVED
- 18 Aug 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT